SandboxAQ launches AQPotency to screen drugs without solved protein structures

Jack Hidary is putting SandboxAQ's numerical models behind Claude, with claimed pricing of $1 per 1,000 molecule-target comparisons.

By · Published

Charcoal sketch showing simplified molecular structures and data points representing drug screening with SandboxAQ's AQPotency product.

Jack Hidary is putting SandboxAQ's numerical models behind Claude, with claimed pricing of $1 per 1,000 molecule-target comparisons.